Oyler John

Chief Executive Officer, DirectorBeOne Medicines Ltd. (ONC) · full profile →Form 4 · filed Jul 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$34.6M
Net Open-Market Flow
-$34.6M
Transactions
16
15 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 21, 2026Sell(S)15K$316.26$4.9M46K
Jul 21, 2026Sell(S)20K$316.91$6.3M26K
Jul 21, 2026Sell(S)8K$318.41$2.5M18K
Jul 21, 2026Sell(S)16K$319.29$5.0M2K
Jul 21, 2026Sell(S)2K$320.06$749K0
Jul 20, 2026Sell(S)14K$312.96$4.5M4K
Jul 20, 2026Sell(S)2K$313.91$581K2K
Jul 20, 2026Sell(S)2K$315.26$477K803
Jul 20, 2026Sell(S)523$316.14$165K280
Jul 20, 2026Sell(S)280$318.30$89K0
Jul 20, 2026Sell(S)5K$310.08$1.6M9K
Jul 20, 2026Sell(S)6K$310.75$1.9M3K
Jul 20, 2026Sell(S)3K$311.80$906K0
Jul 20, 2026Option exercise(M)34K$119.96$4.1M34K
Jul 20, 2026Sell(S)15K$312.29$4.8M18K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 20, 2026Option exercise(M)442K$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001042047-26-000017) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.